Generic HIV prevention drug coming in 2020, Gilead says
Gilead drug remdesivir shows promise in two coronavirus trials
Gilead loses monopoly control of its blockbuster hepatitis C medicine in China | Médecins Sans Frontières Access Campaign
FDA approves Gilead's multi-drug resistant HIV-1 treatment
United States v. Gilead: The Fight for PrEP | Bill of Health
Gilead to Slice List Prices of Liver Drugs - WSJ
Gilead Wins Key Patent Rights Suit Over PrEP Drugs for Preventing HIV - The New York Times
Gilead reaches multiyear agreement with White House to donate PrEP
India and Pakistan ramp up remdesivir production under Gilead deal | Financial Times
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Gilead, U.S. fight in court over HIV prevention drug
Trump administration sues Gilead over HIV drugs
Gilead prices remdesivir at $2,340 per patient for developed countries
Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Top Research Reports for JPMorgan, Gilead Sciences & CSX
Gilead reports 3% revenue growth in Q1 2022
Pharma giant Gilead sued for 'withholding' safer HIV drug | PinkNews
Sovaldi: Who's to Blame for the $1,000 a Day Cure? - Knowledge at Wharton
Gilead says generic Truvada will be available in 2020
